Clinical Trials Browser

Phase 2 × Recruiting × Extensive Small Cell Lung Cancer × Clear all

NCT06125041 2023-11-09

Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC

Phase 2 Recruiting

Extensive Small Cell Lung Cancer